19

2018-11

Announcement of the full text of the environmental impact report of the renovation and expansion project

According to the relevant provisions of the "Environmental Impact Assessment Law" and the "Interim Measures for Public Participation in Environmental Impact Assessment".

24

2018-10

The second public announcement of the environmental impact assessment of the reconstruction and expansion project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd.

According to the relevant provisions of the "Interim Measures for Public Participation in Environmental Impact Assessment", the relevant information on the environmental impact assessment of the "Reconstruction and Expansion Project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd." is now announced.

08

2018-10

Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Reconstruction and Expansion Project Environmental Impact Assessment Public Participation First Public Announcement

According to the relevant provisions of the "Interim Measures for Public Participation in Environmental Impact Assessment," combined with the characteristics of the construction project

06

2015-10

2015 company employee training

From September 29th to 30th, 2015, the company took pictures after training all employees on safety, GMP, ICQ7, TPM and corporate culture.

23

2015-01

Chongqing Huafang Wulingshan Pharmaceutical Co., Ltd. Enterprise Technology Center

Chongqing Huafang Wulingshan Pharmaceutical Co., Ltd. is recognized as a municipal enterprise technology center

22

2015-01

High-tech products

Artemisinin, artemether, dihydroartemisinin, artesunate

06

2014-11

On-site review meeting of Huawu Pharmaceutical Technology Center

On November 6, 2014, experts from Chongqing State Taxation Bureau, Local Taxation Bureau, Chongqing Science and Technology Commission, Chongqing Customs, Chongqing Finance Bureau and other experts reviewed Huawu Pharmaceutical Technology Center.

30

2014-10

Huawu Pharmaceutical successfully passed the evaluation of occupational health control effects

On October 30, 2014, Huawu Pharmaceutical's overall relocation project passed the occupational health control effect evaluation and on-site acceptance

30

2014-10

Zhang Zongqing, Director of Chongqing Quality Supervision Bureau, visited Huawu Pharmaceutical

On October 30, Zhang Zongqing, director of Chongqing Quality Supervision Bureau, led a team to Huawu Pharmaceutical for investigation.

21

2014-10

Ma Qichang, deputy director of Chongqing Economic and Information Commission, visited Huawu Pharmaceutical

On October 21, Ma Qichang, deputy director of Chongqing Economic and Information Commission, accompanied by the leaders of Youyang County Economic and Information Commission, visited Huawu Pharmaceutical for investigation.